10-Q: Crescent Capital BDC Reports First Quarter 2024 Financial Results

Sentiment:

Quarterly Report


Crescent Capital BDC's first quarter 2024 filing details its investment portfolio, financial performance, and key metrics.

Worse than expectedThe company's net realized and unrealized gains (losses) on investments was $4.3 million for the three months ended March 31, 2024, compared to a loss of $9.9 million for the same period in 2023.

Summary

  • This document is a 10-Q filing for Crescent Capital BDC, Inc. for the quarter ended March 31, 2024.
  • It provides details on the company's debt and equity investments, including interest rates, maturity dates, and fair values.
  • The filing includes a consolidated schedule of investments, statements of assets and liabilities, operations, cash flows, and changes in net assets.
  • The company's investment portfolio is diversified across various industries, including healthcare, software, commercial services, and consumer services.
  • The document also includes information on the company's debt obligations, including its SPV Asset Facility, SMBC Corporate Revolving Facility, and various series of unsecured notes.
  • The company's weighted average yield on income producing securities was 12.3% as of March 31, 2024.
  • The company's asset coverage ratio was 189% as of March 31, 2024.
  • The company had $171.0 million in unfunded commitments to portfolio companies as of March 31, 2024.
  • The company's net investment income for the three months ended March 31, 2024 was $23.4 million or $0.63 per share.
  • The company's net realized and unrealized gains (losses) on investments was $4.3 million for the three months ended March 31, 2024.

Sentiment

Score: 5

Explanation: The document presents a mixed picture, with positive net investment income but negative net realized and unrealized gains. The overall sentiment is neutral, reflecting the inherent risks and uncertainties in the company's investment portfolio.

Positives

  • The company's weighted average yield on income producing securities was 12.3% as of March 31, 2024.
  • The company's asset coverage ratio was 189% as of March 31, 2024.
  • The company's net investment income for the three months ended March 31, 2024 was $23.4 million or $0.63 per share.

Negatives

  • The company had $171.0 million in unfunded commitments to portfolio companies as of March 31, 2024.
  • The company's net realized and unrealized gains (losses) on investments was $4.3 million for the three months ended March 31, 2024.

Risks

  • The company is subject to valuation risk due to its investments in illiquid debt and equity securities of private companies.
  • The company is subject to interest rate risk, as its net investment income will be affected by the difference between the rate at which it invests and the rate at which it borrows.
  • The company is subject to currency risk, as it may make investments that are denominated in a foreign currency.
  • The company's portfolio companies may default on their obligations, which could result in losses for the company.
  • The company's ability to access sufficient debt and equity capital may be adversely affected by a breach of its debt covenants.

Future Outlook

The company expects its investment activity to vary substantially from period to period depending on many factors, including the general economic environment, the amount of capital available, and the competitive environment for investments.

Industry Context

The company operates in the specialty finance industry, focusing on lending to middle-market companies. The company's performance is influenced by factors such as the general economic environment, the amount of capital available, and the competitive environment for investments.

Comparison to Industry Standards

  • The document does not provide specific comparisons to industry standards or competitors.
  • However, the document does provide detailed information on the company's investment portfolio, financial performance, and key metrics, which can be used to assess its performance relative to industry benchmarks.
  • The document lists a number of comparable companies in the portfolio, but does not provide specific comparisons to their results.

Legal Proceedings

  • The company is party to certain lawsuits in the normal course of business, including proceedings relating to the enforcement of its rights under loans to or other contracts with its portfolio companies.

Related Party Transactions

  • A portion of the outstanding shares of the Companys common stock is owned by Crescent, its employees and certain officers and directors of the Company.
  • Crescent is also the majority member of the Adviser and sole member of the Administrator.
  • The Company has entered into a license agreement with Crescent under which Crescent granted the Company a non-exclusive, royalty-free license to use the name Crescent Capital.
  • The Adviser has entered into a resource sharing agreement with Crescent.
  • Sun Life, which owns a majority interest in the Adviser, has committed to provide secondary market support and will over time purchase up to $20,000 of the combined companys common stock via a share purchase program.
  • Sun Life is the sole lender of the Companys Series 2023A Unsecured Notes and a $10,000 participating lender in the Companys Series 2021A Unsecured Notes.

Stakeholder Impact

  • The company's financial performance and investment decisions directly impact its shareholders, who receive dividends and are exposed to the risks and rewards of the company's investments.
  • The company's employees and management are responsible for the day-to-day operations and investment decisions, and their performance is critical to the company's success.
  • The company's portfolio companies are impacted by the company's investment decisions and ongoing monitoring, which can affect their financial stability and growth prospects.
  • The company's creditors are impacted by the company's ability to repay its debt obligations, which is dependent on the performance of its investment portfolio.

Next Steps

  • The company will continue to monitor its portfolio companies and assess the risk profile of each investment.
  • The company will continue to evaluate opportunities to leverage its portfolio and generate additional liquidity.
  • The company will continue to evaluate opportunities to make new investments.

Key Dates

DateDescription
February 5, 2015Crescent Capital BDC, Inc. was formed as a Delaware corporation.
June 26, 2015The Company commenced investment operations.
January 30, 2020The Company changed its state of incorporation from Delaware to Maryland.
February 3, 2020The Company was listed and began trading on the NASDAQ stock exchange.
January 5, 2021Sun Life Financial Inc. acquired a majority interest in Crescent Capital Group LP.
March 9, 2023The Company completed its acquisition of First Eagle Alternative Capital BDC, Inc.
March 31, 2024End of the reporting period for the 10-Q filing.
May 8, 2024Date of the filing of the 10-Q report.
May 2, 2024The Company's Board of Directors declared a regular second quarter cash dividend of $0.42 per share and a supplemental cash dividend of $0.11 per share.
June 17, 2024Payment date for the supplemental cash dividend of $0.11 per share.
June 28, 2024Record date for the regular second quarter cash dividend of $0.42 per share.
July 15, 2024Payment date for the regular second quarter cash dividend of $0.42 per share.

Keywords

debt investments, equity investments, business development company, financial results, interest rates, credit facilities, unfunded commitments, net investment income, fair value, portfolio companies

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.